Patenting Privation (Part III): Empowering Revenge

Patenting Privation (Part III): Empowering Revenge

Just over a year ago on these pages, I continued our look at the patent franchises protecting the defining drugs of our time, Novo Nordisk and Eli Lilly’s diabetes/weight-loss blockbusters, Ozembic/Wegovy and Mounjaro/Zepbound. As you can imagine with drugs of such...
Biglaw Equity Partners Are Seeing A Windfall

Biglaw Equity Partners Are Seeing A Windfall

Ed. Note: Welcome to our daily feature Trivia Question of the Day! According to data collected by American Lawyer, in 2024 by what percentage was profits per equity partner up across the entire Am Law 100? Hint: PEP averages $3,147,269 See the answer on the next page....